Drug approval bodies must tighten rules on conflicts of interest

Speakers ’ conflict of interest raised likelihood of them giving positive testimony about a new drug Related items fromOnMedica Philip Morris knew nicotine is just one part of smoking addiction BMJ report questions swine flu jab transparency Clinicians need better options if we are to stop over-medication ‘Patent to patient’ time is too long and rising for cancer meds Hunt announces Medicines and Medical Devices Safety Review
Source: OnMedica Latest News - Category: UK Health Source Type: news